Lishan Su
0000-0002-0350-5560
University of North Carolina at Chapel Hill School of Medicine
5 papers found
Refreshing results…
Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4– and PD-1–targeted immunotherapy
Molecular clones of genetically distinct hepatitis B virus genotypes reveal distinct host and drug treatment responses
TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice
IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodies
Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination
Missing publications? Search for publications with a matching author name.